131 related articles for article (PubMed ID: 32953734)
1. Interaction between common variants of
Yin J; Hou W; Vogel U; Ma Y; Wang C; Wang H; Sun Z
Ann Transl Med; 2020 Aug; 8(15):934. PubMed ID: 32953734
[TBL] [Abstract][Full Text] [Related]
2. TP53 common variants and interaction with PPP1R13L and CD3EAP SNPs and lung cancer risk and smoking behavior in a Chinese population.
Yin J; Hou W; Vogel U; Li X; Ma Y; Wang C; Wang H; Sun Z
Biomed J; 2022 Feb; 45(1):169-178. PubMed ID: 35351459
[TBL] [Abstract][Full Text] [Related]
3. Association and interaction of NFKB1 rs28362491 insertion/deletion ATTG polymorphism and PPP1R13L and CD3EAP related to lung cancer risk in a Chinese population.
Yin J; Wang H; Vogel U; Wang C; Hou W; Ma Y
Tumour Biol; 2016 Apr; 37(4):5467-73. PubMed ID: 26563375
[TBL] [Abstract][Full Text] [Related]
4. 19p13.3-GADD45B common variants and 19q13.3-PPP1R13L and 19q13.3-CD3EAP in lung cancer risk among Chinese.
Hou W; Yin J; Vogel U; Sun Z; Liang D
Chem Biol Interact; 2017 Nov; 277():74-78. PubMed ID: 28870783
[TBL] [Abstract][Full Text] [Related]
5. HapMap-based study identifies risk sub-region on chromosome 19q13.3 in relation to lung cancer among Chinese.
Yin J; Vogel U; Wang H; Ma Y; Wang C; Liang D; Liu J; Yue L; Zhao Y; Ma J
Cancer Epidemiol; 2013 Dec; 37(6):923-9. PubMed ID: 24140460
[TBL] [Abstract][Full Text] [Related]
6. NFKB1 common variants and PPP1R13L and CD3EAP in relation to lung cancer risk in a Chinese population.
Yin J; Yin M; Vogel U; Wu Y; Yao T; Cheng Y; Sun Z; Hou W; Wang C
Gene; 2015 Aug; 567(1):31-5. PubMed ID: 25917613
[TBL] [Abstract][Full Text] [Related]
7. GLTSCR1, ATM, PPP1R13L and CD3EAP Genetic Variants and Lung Cancer Risk in a Chinese Population.
Yin JY; Ma YG; Vogel U; Liu DH; Sun ZX
Curr Med Sci; 2018 Aug; 38(4):734-740. PubMed ID: 30128886
[TBL] [Abstract][Full Text] [Related]
8. Common variants of pro-inflammatory gene IL1B and interactions with PPP1R13L and POLR1G in relation to lung cancer among Northeast Chinese.
Yin J; Wang C; Vogel U; Ma Y; Zhang Y; Wang H; Sun Z; Du S
Sci Rep; 2023 May; 13(1):7352. PubMed ID: 37147350
[TBL] [Abstract][Full Text] [Related]
9. A specific diplotype defined by PPP1R13L rs1970764, CD3EAP rs967591 and ERCC1 rs11615 and lung cancer risk in a Chinese population.
Yin J; Vogel U; Ma Y; Wang H; Wang C; Liang D; Yue L; Ma J; Li X
Lung Cancer; 2012 Jun; 76(3):286-91. PubMed ID: 22335888
[TBL] [Abstract][Full Text] [Related]
10. Fine-mapping markers of lung cancer susceptibility in a sub-region of chromosome 19q13.3 among Chinese.
Yin J; Wang H; Vogel U; Wang C; Ma Y; Hou W; Zhang Y; Guo L; Li X
Oncotarget; 2016 Sep; 7(38):60929-60939. PubMed ID: 27183913
[TBL] [Abstract][Full Text] [Related]
11. Effects of PPP1R13L and CD3EAP variants on lung cancer susceptibility among nonsmoking Chinese women.
Yin J; Guo L; Wang C; Wang H; Ma Y; Liu J; Liang D; Ma J; Zhao Y
Gene; 2013 Jul; 524(2):228-31. PubMed ID: 23624123
[TBL] [Abstract][Full Text] [Related]
12. Association of PPP1R13L and CD3EAP polymorphisms with risk and survival of non-small cell lung cancer in Chinese non-smoking females.
Feng X; Fang X; Xia L; Ren Y; Li X; Quan X; Zhou B
Oncotarget; 2017 Oct; 8(45):78749-78756. PubMed ID: 29108262
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D
Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
[TBL] [Abstract][Full Text] [Related]
14. Hapmap-based evaluation of ERCC2, PPP1R13L, and ERCC1 and lung cancer risk in a Chinese population.
Yin J; Vogel U; Wang C; Liang D; Ma Y; Wang H; Yue L; Liu D; Ma J; Sun X
Environ Mol Mutagen; 2012 Apr; 53(3):239-45. PubMed ID: 22351191
[TBL] [Abstract][Full Text] [Related]
15. A single-nucleotide polymorphism in the TP53 and MDM-2 gene modifies breast cancer risk in an ethnic Arab population.
Alshatwi AA; Hasan TN; Shafi G; Alsaif MA; Al-Hazzani AA; Alsaif AA
Fundam Clin Pharmacol; 2012 Jun; 26(3):438-43. PubMed ID: 21477265
[TBL] [Abstract][Full Text] [Related]
16. The cell cycle regulatory gene polymorphisms TP53 (rs1042522) and MDM2 (rs2279744) in lung cancer: a meta-analysis.
Bulgakova O; Kussainova A; Bersimbaev R
Vavilovskii Zhurnal Genet Selektsii; 2020 Nov; 24(7):777-784. PubMed ID: 33959694
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies.
Elshazli RM; Toraih EA; Elgaml A; Kandil E; Fawzy MS
Gene; 2020 Apr; 734():144391. PubMed ID: 32001373
[TBL] [Abstract][Full Text] [Related]
18. TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis.
Peng Q; Lao X; Chen Z; Lai H; Deng Y; Wang J; Mo C; Sui J; Wu J; Zhai L; Yang S; Qin X; Li S
PLoS One; 2013; 8(12):e82773. PubMed ID: 24376578
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis.
Gansmo LB; Lie BA; Mæhlen MT; Vatten L; Romundstad P; Hveem K; Lønning PE; Knappskog S
Gene; 2021 Aug; 793():145747. PubMed ID: 34077778
[TBL] [Abstract][Full Text] [Related]
20. The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Sinilnikova OM; Antoniou AC; Simard J; Healey S; Léoné M; Sinnett D; Spurdle AB; Beesley J; Chen X; ; Greene MH; Loud JT; Lejbkowicz F; Rennert G; Dishon S; Andrulis IL; ; Domchek SM; Nathanson KL; Manoukian S; Radice P; Konstantopoulou I; Blanco I; Laborde AL; Durán M; Osorio A; Benitez J; Hamann U; Hogervorst FB; van Os TA; Gille HJ; ; Peock S; Cook M; Luccarini C; Evans DG; Lalloo F; Eeles R; Pichert G; Davidson R; Cole T; Cook J; Paterson J; Brewer C; ; Hughes DJ; Coupier I; Giraud S; Coulet F; Colas C; Soubrier F; Rouleau E; Bièche I; Lidereau R; Demange L; Nogues C; Lynch HT; ; Schmutzler RK; Versmold B; Engel C; Meindl A; Arnold N; Sutter C; Deissler H; Schaefer D; Froster UG; ; Aittomäki K; Nevanlinna H; McGuffog L; Easton DF; Chenevix-Trench G; Stoppa-Lyonnet D;
Br J Cancer; 2009 Oct; 101(8):1456-60. PubMed ID: 19707196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
